Literature DB >> 16832055

Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis.

Zhengfan Jiang1, Philippe Georgel, Chenglong Li, Jungwoo Choe, Karine Crozat, Sophie Rutschmann, Xin Du, Tim Bigby, Suzanne Mudd, Sosathya Sovath, Ian A Wilson, Arthur Olson, Bruce Beutler.   

Abstract

The immunovariant N-ethyl-N-nitrosourea-induced mutations Pococurante (Poc) and Lackadaisical were found to alter MyD88, creating striking receptor-selective effects. Poc, in particular, prevented sensing of all MyD88-dependent Toll-like receptor (TLR) ligands except diacyl lipopeptides. Furthermore, Poc-site and classical BB loop mutations caused equivalent phenotypes when engrafted into any TLR/IL-1 receptor/resistance (TIR) domain. These observations, complemented by data from docking studies and site-directed mutagenesis, revealed that BB loops and Poc sites interact homotypically across the receptor:adapter signaling interface, whereas the C-terminal alpha(E)-helices support adapter:adapter and receptor:receptor oligomerization. We have thus defined the TIR domain surface that mediates association between TLRs and MyD88 and the surface required for MyD88 or TLR oligomerization. Moreover, MyD88 engages individual TLRs differently, suggesting the feasibility of selective pharmacologic TIR domain receptor blockade.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16832055      PMCID: PMC1544157          DOI: 10.1073/pnas.0603804103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

Review 1.  Toll-like receptors: critical proteins linking innate and acquired immunity.

Authors:  S Akira; K Takeda; T Kaisho
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

Review 2.  Roles of Toll-like receptors in innate immune responses.

Authors:  K Takeda; S Akira
Journal:  Genes Cells       Date:  2001-09       Impact factor: 1.891

3.  Discrimination of bacterial lipoproteins by Toll-like receptor 6.

Authors:  O Takeuchi; T Kawai; P F Mühlradt; M Morr; J D Radolf; A Zychlinsky; K Takeda; S Akira
Journal:  Int Immunol       Date:  2001-07       Impact factor: 4.823

4.  Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.

Authors:  O Takeuchi; A Kaufmann; K Grote; T Kawai; K Hoshino; M Morr; P F Mühlradt; S Akira
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

5.  TIRAP: an adapter molecule in the Toll signaling pathway.

Authors:  T Horng; G M Barton; R Medzhitov
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

6.  Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway.

Authors:  Chunsheng Li; Jozef Zienkiewicz; Jacek Hawiger
Journal:  J Biol Chem       Date:  2005-04-22       Impact factor: 5.157

7.  Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.

Authors:  K A Fitzgerald; E M Palsson-McDermott; A G Bowie; C A Jefferies; A S Mansell; G Brady; E Brint; A Dunne; P Gray; M T Harte; D McMurray; D E Smith; J E Sims; T A Bird; L A O'Neill
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

8.  Toll-like receptor 6-independent signaling by diacylated lipopeptides.

Authors:  Ute Buwitt-Beckmann; Holger Heine; Karl-Heinz Wiesmüller; Günther Jung; Roland Brock; Shizuo Akira; Artur J Ulmer
Journal:  Eur J Immunol       Date:  2005-01       Impact factor: 5.532

9.  Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.

Authors:  Y Xu; X Tao; B Shen; T Horng; R Medzhitov; J L Manley; L Tong
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

10.  CD14 is required for MyD88-independent LPS signaling.

Authors:  Zhengfan Jiang; Philippe Georgel; Xin Du; Louis Shamel; Sosathya Sovath; Suzanne Mudd; Michael Huber; Christoph Kalis; Simone Keck; Chris Galanos; Marina Freudenberg; Bruce Beutler
Journal:  Nat Immunol       Date:  2005-05-15       Impact factor: 25.606

View more
  58 in total

Review 1.  Important aspects of Toll-like receptors, ligands and their signaling pathways.

Authors:  Z L Chang
Journal:  Inflamm Res       Date:  2010-07-01       Impact factor: 4.575

2.  TIR domain-containing adaptor SARM is a late addition to the ongoing microbe-host dialog.

Authors:  Qing Zhang; Christian M Zmasek; Xiaohui Cai; Adam Godzik
Journal:  Dev Comp Immunol       Date:  2010-11-24       Impact factor: 3.636

3.  Oncogenically active MYD88 mutations in human lymphoma.

Authors:  Vu N Ngo; Ryan M Young; Roland Schmitz; Sameer Jhavar; Wenming Xiao; Kian-Huat Lim; Holger Kohlhammer; Weihong Xu; Yandan Yang; Hong Zhao; Arthur L Shaffer; Paul Romesser; George Wright; John Powell; Andreas Rosenwald; Hans Konrad Muller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; J R Cook; Denny D Weisenburger; Wing C Chan; Louis M Staudt
Journal:  Nature       Date:  2010-12-22       Impact factor: 49.962

4.  Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain.

Authors:  Pragnesh Mistry; Michelle H W Laird; Ryan S Schwarz; Shannon Greene; Tristan Dyson; Greg A Snyder; Tsan Sam Xiao; Jay Chauhan; Steven Fletcher; Vladimir Y Toshchakov; Alexander D MacKerell; Stefanie N Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

Review 5.  Dissecting innate immunity by germline mutagenesis.

Authors:  Sophie Rutschmann; Kasper Hoebe
Journal:  Immunology       Date:  2008-01-18       Impact factor: 7.397

6.  Poxviral protein A46 antagonizes Toll-like receptor 4 signaling by targeting BB loop motifs in Toll-IL-1 receptor adaptor proteins to disrupt receptor:adaptor interactions.

Authors:  Julianne Stack; Andrew G Bowie
Journal:  J Biol Chem       Date:  2012-05-16       Impact factor: 5.157

Review 7.  TLRs and innate immunity.

Authors:  Bruce A Beutler
Journal:  Blood       Date:  2008-08-29       Impact factor: 22.113

Review 8.  Chemical mutagenesis: a new strategy against the global threat of infectious diseases.

Authors:  Etienne Richer; Salman T Qureshi; Silvia M Vidal; Danielle Malo
Journal:  Mamm Genome       Date:  2008-06-17       Impact factor: 2.957

9.  Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger.

Authors:  Ben A Croker; Brian R Lawson; Sophie Rutschmann; Michael Berger; Celine Eidenschenk; Amanda L Blasius; Eva Marie Y Moresco; Sosathya Sovath; Louise Cengia; Leonard D Shultz; Argyrios N Theofilopoulos; Sven Pettersson; Bruce Alan Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-19       Impact factor: 11.205

Review 10.  Malignant pirates of the immune system.

Authors:  Lixin Rui; Roland Schmitz; Michele Ceribelli; Louis M Staudt
Journal:  Nat Immunol       Date:  2011-09-20       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.